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Introduction
Microcephaly is an important neurologic sign
in childhood and its definition and consistency is not
uniformly shared(1). The occipitofrontal head circum-
ference (OFC) should be determined by placing a
measuring tape around the cranial vault to include
the widest part of the forehead and the most promi-
nent part of the occipital area to arrive at the largest
possible measurement. If abnormal, at least a second
measurement should be performed to confirm the
result. Microcephaly is usually defined as an OFC
more than 2 SDs below the mean for age and gen-
der(2), but some clinicians and researchers prefer to
define severe microcephaly as an OFC more than 3
SDs below the mean(3).
Following the first definition, statistically, 2.3%
of children should be microcephalic. However, pub-
lished estimates for OFC ≤2 SD at birth are far
lower, at 0.56%8 and 0.54%, and this difference may
be justified by a non-normal distribution, the possi-
bility of postnatal development of microcephaly, or
incomplete neonatal ascertainment. Severe micro-
cephaly considered as an OFC ≤3 SD at birth would
be expected in 0.1% of children if normal distribu-
tion is assumed, which agrees with the published
estimate of 0.14% of neonates(4). 
Taking in account clinical terminology and
nosology and their implications when dealing, in the
medical literature, with the term microcephaly, we
should consider a complex of cerebral developmen-
tal anomalies directly affecting neurogenesis, or neu-
rogenic mitosis, rather than growth of the skull (e.g.
Craniosynostosis), so the term 'micrencephaly'
should be preferred.
Classification
Several classifications of microcephaly can be
adopted. Microcephaly can be considered isolated, or
it may be associated with other congenital anomalies
as in chromosomal or syndromic conditions(5,6,7,8,9,10).
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ABSTRACT
Microcephaly is a clinical finding, defined as a head circumference (HC) more than 2 SDs below the mean for age and gen-
der, that may results from any insult disturbing early brain growth. It can be isolated or can be seen in association with many
genetic syndromes and environmental aetiologies; therefore this condition requires a careful clinical and instrumental evaluation
and a multidisciplinary approach. Microcephaly is usually classified according to its time of onset (eg, congenital or post-natal)
and its association with other anomalies (primary or secondary). To date, for Primary microcephaly seven responsible gene loci
have been identified. In this review we include some sample of monogenic causes and chromosomal aberrations responsible for a
complicated phenotype including microcephaly.
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Microcephaly can present at birth and can be termed
“primary” microcephaly as opposed to “secondary”
microcephaly, which develops later. Indeed the term
primary microcephaly should be used to imply
genetic influences, whereas secondary microcephaly
would designate factors that are environmental in
nature (infectious, vascular, traumatic), but these
terms do not imply a distinct etiology as in the case
of microcephaly presenting in patients with Rett and
Angelman syndromes, in whom microcephaly has a
well-described genetic causes, the reduction of OFC
growth velocity develops during late infancy or early
childhood(11). 
Cerebral Magnetic Resonance Imaging (MRI)
is often helpful for definitive diagnosis, prognosis,
and genetic counseling, thus a MRI-based classifica-
tion of microcephaly has been proposed(12).
Etiopathogenesis
Etiopathogenesis is very heterogeneous.
Enviromental or genetic factors responsible for brain
growth impairment must be considered and may act
prenatally, perinatally, or postnatally(13,14).
Environmental causes include hypoxic-ischemic
encephalopathy, cerebral infections, vascular or viral
induced disruption, intrauterine infection (eg, with
rubella, cytomegalovirus, or toxoplasmosis) terato-
gens such as alcohol, hydantoin, and radiation;
maternal phenylketonuria; and poorly controlled
maternal diabetes. Genetic factors responsible for
isolated microcephaly are mostly mendelian autoso-
mal dominant, recessive, or X- linked genes. Rarely,
a ring chromosome, mosaicism, or an apparently bal-
anced translocation can be found. Several syndromes
present with microcephaly and these syndromic
forms can be due to gross chromosomal causes as
well as single gene mutations and contiguous gene
deletions or duplications. 
Enviromental causes
Hypoxic–ischemic encephalopathy (HIE) can
be considered the main cause of acquired micro-
cephaly(15,16,17,18). A severe neurological impairment
characterized by cerebral palsy, epilepsy, neurosen-
sorial deficits and cognitive impairment is frequent.
Preterm newborns, at term newborns with moderate
or severe HIE and monochorionic monoamniotic
twins (particularly at risk of twin-twin transfusion
syndrome) can be considered particularly at risk(19,20).
All these conditions play a very important role in
determining morbidity and mortality rates, especially
in neonatal age, when many other risk factors (pre-
maturity(21,22), twinning, nosocomial infections
(23,24,25,26), chemical mediators(27,28) may add their




“Microcephaly vera” or true microcephaly  has
been defined as being present at birth, uncomplicated
by associated anomalies, with a normal pregnancy,
delivery and postnatal period. It refers to the clinical
finding of a OFC less than 3 standard deviations and
it is now labeled “autosomal recessive primary
microcephaly” or MCPH1 (MIM #251200) caused
by mutation in the gene encoding microcephalin on
chromosome 8p23. Incidence figures vary depending
on the country studied and is considered about 1 per
million in Yorkshire, but 1/10.000 in Pakistan due to
the high consanguinity rates. Several genes are
responsible for this heterogeneous disorder.
Autosomal Dominant microcephaly
(MIM#156580)
Several reports describe microcephaly without
neurologic or dysmorphic features or severe cogni-
tive impairment, with an apparent autosomal domi-
nant mode of inheritance. Clinically stature is in the
normal range and receding foreheads is not a pecu-
liar feature. In these microcephalic patients cognitive
performances are in the mild or borderline level.
X-linked Microcephaly (MIM#309500)
Several neurobehavioral and clinical phenotype
are described, ranging from microcephalic individu-
als with short stature, moderate microcephaly, nor-
mal facial features and a normal neurologic status
with cognitive impairment, to patients affected by
Aristaless gene (ARX) mutations, that cause a vari-
ety of different conditions including syndromic and
non syndromic cognitive impairment, micro o
macrocephaly, X-linked lissencephaly with ambigu-
ous genitalia.
Syndromic forms of microcephaly
Online Mendelian Inheritance in Man (OMIM)
lists approximately 500 entries for microcephaly
(including both the isolated and syndromic forms).
In several disorders with multiple anomalies,
such as Microcephaly with lymphedema and chori-
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oretinal dysplasia, or Microcephaly - Capillary syn-
drome, microcephaly is reported as a defining fea-
ture. In a retrospective study based on cases of
microcephaly with simplified gyral pattern, the most
frequent associated extra-encephalic malformation
resulted to be ocular defects(31).
Microcephaly is also a common finding in tri-
somies. Many syndromes are characterized by a phe-
notype including microcephaly, brachydactyly, syn-
dactyly, short stature and cognitive impairment, such
as the Rubinstein-Taybi syndrome, the Tsukahara
syndrome, the Filippi syndrome, the Feingold syn-
drome, and the Tonoki syndrome.
Microcephaly has been found also in syn-
dromes belonging to the group of ectodermaldys-
plasias (EDs), which are developmental impairments
of ectodermal-derived tissue, such as in Tricho-
rhino-phalangeal syndrome and in the X linked dis-
order Hypohidrotic (anhidrotic) ectodermal dysplasia
(HED)(32,33).
Microdeletion/duplication syndromes
Several common syndromes, such as mono-
somy 1p36 (OMIM 607872), Wolf-Hirschhorn
(OMIM 194490), Cri-du Chat (OMIM 123450),
monosomy 9p (OMIM 158170), 9q34.3 microdele-
tions (OMIM 610253), Jacobsen (OMIM 147791),
Miller–Dieker (OMIM 247200) and 22q13.3
(OMIM 606232) are associated with terminal sub-
telomeric deletions of chromosomes 1p, 4p, 5p, 9p,
9q, 11q, 17p and 22q, respectively. Submicroscopic
chromosomal aberrations are considered to comprise
up to 15% of all mutations underlying monogenic
diseases and well-known cause of neurodevelopment
impairment.
The advent of array CGH has allowed to recog-
nize a characteristic phenotype for some of these
rearrangements. Substantial number of rearrange-
ments involving the subtelomeric regions of all chro-
mosomes have been reported to cause birth defects
and mental retardation.
Microcephaly with multiorgan involvement is
frequently reported, but rather nonspecific finding in
submicroscopic chromosomal aberrations, in sub-
telomeric deletions (>30%) and in several cases of
simplex and complex chromosomal rearrangement
on diverse chromosomes investigated by FISH and
array-CGH(34).
Common features of chromosome 2p15p16.1
microdeletion syndrome are dysmorphic facial fea-
tures, congenital and progressive microcephaly, mild
to moderate developmental delay, neurodevelopmen-
tal abnormalities, structural brain anomalies includ-
ing cortical dysplasia/pachygyria, renal anomalies(35).
Monosomy of chromosome 6p terminal region
causes a well defined spectrum of brain, craniofacial
and organ malformation, including microcephaly(36).
Microdeletions and Microduplications of
22q11.21 are reported to share several phenotypic
characteristics, (dysmorphic facial features, velopha-
ryngeal insufficiency, congenital heart disease, uro-
genital abnormalities, and immunologic defects).
Both syndromes may present with microcephaly(37).
Deletions of 14q13 have been associated to
microcephaly, micrognathia, facial dysmorphisms,
generalized muscular hypertonicity, deleyedpsy-
chomotordevelopment, seizures and holoprosen-
cephaly(38).
Conclusions
The diagnosis of microcephaly can be a chal-
lenge for the physicians in order to identify the cor-
rect one between various pathological conditions. A
diagnostic flow-chart describe a possible clinical
work-up (Figure 1)(39).
A multidisciplinary approach is necessary
involving the obstetrician, the neonatologist/pediatri-
cian, the clinical laboratory geneticist, the child neu-
ropsychiatrist and the neuroradiologist. 
Figure 1: Evaluation of congenital microcephaly.
Adapted from Ashwal S, Michelson D, Plawner L,
Dobyns WB, Quality Standards Subcommettee of the
American Academy of Neurology, Practice committee of
the Child Neurology Society. Practice parameter:
Evaluation of the child with microcephaly (an evidence-
based review): report of the Quality Standards
Subcommittee of the American Academy of Neurology
and the Practice Committee of the Child Neurology
Society. Neurology 2009 Sep 15; 73 (11): 887-97 
330 E. Piro, V. Antona et Al
References
1) Leviton A, Holmes LB, Allred EN, Vargas J.
Methodologic issues in epidemiologic studies of conge-
nital microcephaly. Early Hum Dev 2002; 69: 91-105.
2) Opitz JM, Holt MC. Microcephaly: general considera-
tions and aids to nosology. J Craniofac Genet Dev Biol
1990; 10: 175-204.
3) Barkovich AJ, Ferriero DM, Barr RM, Gressens P,
Dobyns WB, Truwit CL, Evrard P. Microlissencephaly:
a heterogeneous malformation of cortical development.
Neuropediatrics 1999; 29: 113-9.
4) Dolk H. The predictive value of microcephaly during
the first year of life for mental retardation at seven
years. Dev Med Child Neurol 1991; 33: 974-83.
5) Corsello G, Giuffrè M. Congenital Malformations. J
Matern Fetal Neonatal Med 2012; 25 (S1): 25-29.
6) Puccio G, Giuffrè M, Piccione M, Piro E, Rinaudo G,
Corsello G. Intrauterine growth restriction and conge-
nital malformations: a retrospective epidemiological
study. Ital J Pediatr 2013; 39:23. doi: 10.1186/1824-
7288-39-23.
7) Ghirri P, Scaramuzzo RT, Bertelloni S, Pardi D,
Celandroni A, Cocchi G, Danieli R, De Santis L, Di
Stefano MC, Gerola O, Giuffrè M, Gragnani GS,
Magnani C, Meossi C, Merusi I, Sabatino G, Tumini S,
Corsello G, Boldrini A. Prevalence of hypospadias in
Italy according to severity, gestational age and
birthweight: an epidemiological study. Ital J Pediatr
2009; 35: 18.
8) Giuffrè M, Schierz IM, La Placa S. Newborn with pre-
natal diagnosis of CAM. Area Pediatrica 2011; 12 (1):
25-26.
9) Martines F, Martinciglio G, Bucalo C, Banco A.
Neurovascular conflict in patient with tinnitus and
essential hypertension: case report. Otorinolaringol
2008; 58: 191-196.
10) Martines F, Pangaro A, Martines E, Ménière’s diseases
and neurovascular cross-compression: case report.
Otorinolaringol 2009; 59: 65-69.
11) Woods CG: Human microcephaly . Curr Opin
Neurobiol 2004: 14: 112-17.
12) Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD,
Dobyns WB. A developmental and genetic classifica-
tion for malformations of cortical development: update
2012. Brain. 2012;135(Pt 5):1348-69. doi:
10.1093/brain/aws019.
13) Martines F, Martines E, Mucia M, Sciacca V, Salvago
P. Prelingual sensorineural hearing loss and infants at
risk: Western Sicily report . Int J Pediatr
Otorhinolaryngol 2013; 77(4):513-8; doi:
10.1016/j.ijporl.2012.12.023. 
14) Salvago P, Martines E, Martines F. Prevalence and risk
factors for sensorineural hearing loss: Western Sicily
overview. Eur Arch Otorhinolaryngol 2013; doi:
10.1007/s00405-013-2379-2
15) Martines F, Salvago P, Bentivegna D, Bartolone A,
Dispenza F, Martines E. Audiologic profile of infants at
risk: experience of a Western Sicily tertiary care centre.
Int J Pediatr Otorhinolaryngol. 2012 Sep; 76(9): 1285-
91.
16) Martines F, Porrello M, Ferrara M, Martines M,
Martines E. Newborn hearing screening project using
transient evoked otoacoustic emissions: Western Sicily
experience. Int. J. Pediatr. Otorhinolaryngol. 2007;
71(1): 107-112.
17) Martines F, Bentivegna D, Ciprì S, Costantino C,
Marchese D, Martines E. On the threshold of effective
well infant nursery hearing screening in Western Sicily.
Int. J. Pediatr. Otorhinolaryngol. 2012; 76: 423-427.
18) Martines F, Martines E, Ballacchino A, Salvago P.
Speech perception outcomes after cochlear implanta-
tion in prelingually deaf infants: The Western Sicily
experience. Int J Pediatr Otorhinolaryngol. 2013 Feb
18; doi: 10.1016/j.ijporl.2013.01.023.
19) Corsello G, Piro E. The world of twins: an update. J
Matern Fetal Neonatal Med. 2010; 23 Suppl 3: 59-62.
20) Giuffrè M, Piro E, Corsello G. Prematurity and twin-
ning. J Matern Fetal Neonatal Med. 2012: 25 Suppl 3:
6-10.
21) Schierz IAM, Giuffrè M, Piro E, Ortolano R, Siracusa
F, Pinello G, La Placa S, Corsello G. Predictive factors
of abdominal compartment syndrome in neonatal age.
Am J Perinatol 2013; doi: 10.1055/s-0033-1334447.
22) Schierz IAM, La Placa S, Giuffrè M, Montalbano G,
Lenzo M, Corsello G. Transient hepatic nodular
lesions associated with patent ductus venosus in pre-
term infants. Am J Perinatol 2011; 28 (3): 177-180.
23) Cipolla D, Giuffrè M, Mammina C, Corsello G.
Prevention of nosocomial infections and surveillance of
emerging resistances in NICU. J Matern Fetal Neonatal
Med 2011; 24 (S1): 23-26.
24) Mammina C, Di Carlo P, Cipolla D, Giuffrè M,
Casuccio A, Di Gaetano V, Plano MR, D'Angelo E,
Titone L, Corsello G. Surveillance of multidrug-resis-
tant gram-negative bacilli in a neonatal intensive care
unit; prominent role of cross transmission. Am J Infect
Control 2007; 35 (4): 222-230.
25) Giuffrè M, Cipolla D, Bonura C, Geraci DM, Aleo A,
Di Noto S, Nociforo F, Corsello G, Mammina C.
Epidemic spread of ST-1-MRSA-IVa in a neonatal
intensive care unit, Italy. BMC Pediatr 2012; 8, 12: 64.
26) Giuffrè M, Cipolla D, Bonura C, Geraci DM, Aleo A,
Di Noto S, Nociforo F, Corsello G, Mammina C.
Outbreak of colonizations by extended-spectrum beta-
lactamase-producing Escherichia coli sequence type
131 in a neonatal intensive care unit, Italy. Antimicrob
Resist Infect Control 2013; 2: 8; doi:10.1186/2047-
2994-2-8.
27) David S, Bucchieri F, Corrao S, Czarnecka AM,
Campanella C, Farina F, Peri G, Tomasello G, Sciumè
C, Modica G, La Rocca G, Anzalone R, Giuffre M,
Conway de Macario E, Macario AJL, Cappello F,
Zummo G. Hsp10: anatomic distribution, functions,
and involvement in human disease. Front Biosci (Elite
Ed) 2013; E5: 768-778.
28) Lo Iacono M, Anzalone R, Corrao S, Giuffrè M, Di
Stefano A, Giannuzzi P, Cappello F, Farina F, La Rocca
G. Perinatal and wharton's jelly-derived mesenchymal
stem cells in cartilage regenerative medicine and tissue
engineering strategies. Open Tissue Engineering and
Regenerative Medicine Journal 2011; 4 (SPEC. ISSUE
1): 72-81.
29) Bentivegna D, Salvago P, Agrifoglio M, et al. The lin-
kage between upper respiratory tract infections and
otitis media: evidence of the ‘united airways concept.
Acta Medica Mediterranea, 2012, 28: 287-290.
30) Maggio M, Martines F, Mucia M, Maggio O. A
Multifactorial pattern for the understanding of the psy-
chological development of the child with impaired hea-
ring and its clinical-therapeutic implications. Acta
Pediatrica Mediterranea, 2006, 22: 41-44.
31) Basel-Vanagaite L, Dobyns WB. Clinical and brain
imaging heterogeneity of severe microcephaly Pediatr
Neurol 2010; 43(1): 7-16.
32) Piccione M, Niceta M, Antona V, Di Fiore A, Cariola F,
Gentile M, Corsello G. Identification of two new muta-
tions in TRPS 1 gene leading to the tricho-rhino-pha-
langeal syndrome type I and III. Am J Med Genet A
2009; 149: 1837-41.
33) Piccione M, Serra G, Sanfilippo C, Andreucci E, Sani I,
Corsello G. A new mutation in EDA gene in X-linked
hypohidrotic ectodermal dysplasia associated with
keratoconus. Minerva Pediatr 2012; 64: 59-64.
34) Viaggi CD, Cavani S, Pierluigi M, Antona V, Piro E,
Corsello G, Mogni M, Piccione M, Malacarne M.
Characterization of a complex rearrangement invol-
ving chromosomes 1, 4 and 8 by FISH and array-CGH.
J Appl Genet 2012; 53: 285-8.
35) Isidor B, Bourdeaut F, Lafon D, Plessis G, Lacaze E,
Kannengiesser C, Rossignol S, Pichon O, Briand A,
Martin-Coignard D, Piccione M, David A, Delattre O,
Jeanpierre C, Sévenet N, Le Caignec C. Wilms’ tumor
in patients with 9q22.3 microdeletion syndrome sug-
gests a role for PTCH1 in nephroblastomas. Eur J Hum
Genet 2012 doi: 10.1038/ejhg.2012.252.
36) Piccione M, Piro E, Serraino F, Cavani S, Ciccone R,
Malacarne M, Pierluigi M, Vitaloni M, Zuffardi O,
Corsello G. Interstitial deletion of chromosome 2p15-
16.1: report of two patients and critical review of cur-
rent genotype-phenotype correlation. Eur J Med Genet
2012; 55(4): 238-44.
37) Piccione M, Antona R, Salzano E, Cavani S, Malacarne
M, Morreale Bubella R, Pierluigi M, Viaggi CD,
Corsello G. Array-CGH and clinical characterization
in a patient with subtelomeric 6p deletion without ocu-
lar dysgenesis. Am J Med Genet A 2012; 158A(1):
150-4.
38) Piccione M, Vecchio D, Cavani S, Malacarne M,
Pierluigi M, Corsello G. The first case of myoclonic
epilepsy in a child with a de novo 22q11.2 microdupli-
cation. Am J Med Genet A 2011; 155A(12): 3054-9.
39) Piccione M, Serra G, Consiglio V, Di Fiore A, Cavani
S, Grasso M, Malacarne M, Pierluigi M, Viaggi C,
Corsello G. 14q13.1-21.1 deletion encompassing the
HPE8 locus in an adolescent with intellectual disability
and bilateral microphthalmia, but without holoprosen-




Via A. Giordano, 3
90127 Palermo 
(Italy)
Microcephaly a clinical-genetic and neurologic approach 331
